We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$1.89T
AUM Growth
+$231B
Cap. Flow
+$19.1B
Cap. Flow %
1.01%
Top 10 Hldgs %
21.09%
Holding
8,715
New
423
Increased
3,809
Reduced
3,216
Closed
305

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.77B
2
MCK icon
McKesson
MCK
+$2.38B
3
SPCX
SpaceX
SPCX
+$2.3B
4
HONA
Honeywell Aerospace
HONA
+$2.05B
5
AMZN icon
Amazon
AMZN
+$1.37B

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.02%
2 Technology 24.63%
3 Financials 9.78%
4 Healthcare 7.32%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IETC icon
5601
iShares US Tech Independence Focused ETF
IETC
$702M
$330K ﹤0.01%
3,078
+269
+10% +$28K
HYSA icon
5602
BondBloxx USD High Yield Bond Sector Rotation ETF
HYSA
$70.1M
$330K ﹤0.01%
22,054
DMAC icon
5603
DiaMedica Therapeutics
DMAC
$345M
$330K ﹤0.01%
46,874
-58,546
-56% -$360K
FJUL icon
5604
FT Vest US Equity Buffer ETF July
FJUL
$1.29B
$330K ﹤0.01%
5,541
ALXO icon
5605
ALX Oncology
ALXO
$277M
$327K ﹤0.01%
157,873
+59,038
+60% +$106K
RPT
5606
Rithm Property Trust
RPT
$100M
$325K ﹤0.01%
22,546
-3,943
-15% -$56.9K
KULR icon
5607
KULR Technology Group
KULR
$119M
$324K ﹤0.01%
85,125
+18,697
+28% +$62.3K
KSTR icon
5608
KraneShares China Technology & Semiconductor STAR 50 Index ETF
KSTR
$392M
$324K ﹤0.01%
+10,000
New +$238K
CHRS icon
5609
Coherus Oncology
CHRS
$218M
$323K ﹤0.01%
230,748
+33,237
+17% +$54.3K
UPGD icon
5610
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$120M
$323K ﹤0.01%
3,940
BSET icon
5611
Bassett Furniture
BSET
$162M
$321K ﹤0.01%
18,127
-1,565
-8% -$23.2K
CRDF icon
5612
Cardiff Oncology
CRDF
$73.1M
$320K ﹤0.01%
246,095
+189,789
+337% +$301K
LXRX icon
5613
Lexicon Pharmaceuticals
LXRX
$1.02B
$319K ﹤0.01%
132,902
-86,960
-40% -$169K
KEN icon
5614
Kenon Holdings
KEN
$3.5B
$319K ﹤0.01%
4,767
+1,114
+30% +$91.2K
CARL
5615
Carlsmed
CARL
$461M
$319K ﹤0.01%
30,699
+19,273
+169% +$203K
VSECU
5616
VSE Corp Tangible Equity Units
VSECU
$1.59B
$319K ﹤0.01%
5,525
-475
-8% -$24.1K
CBIO
5617
Crescent Biopharma
CBIO
$659M
$319K ﹤0.01%
17,698
-879
-5% -$17.2K
SNWV
5618
SANUWAVE Health Inc
SNWV
$40.2M
$316K ﹤0.01%
31,619
+25,826
+446% +$400K
SECT icon
5619
Main Sector Rotation ETF
SECT
$2.87B
$316K ﹤0.01%
4,387
+3,079
+235% +$210K
VNCE icon
5620
Vince Holding Corp
VNCE
$97.1M
$315K ﹤0.01%
44,105
+36,870
+510% +$170K
LINT
5621
Direxion Daily INTC Bull 2X ETF
LINT
$58.7M
$315K ﹤0.01%
+1,230
New +$193K
OGI
5622
Organigram Holdings
OGI
$171M
$314K ﹤0.01%
308,108
-56,076
-15% -$68.5K
ACIU icon
5623
AC Immune
ACIU
$263M
$314K ﹤0.01%
131,815
+42,562
+48% +$117K
IPWR icon
5624
Ideal Power
IPWR
$77.1M
$313K ﹤0.01%
58,396
+37,336
+177% +$190K
MRDN
5625
Meridian Holdings Inc
MRDN
$176M
$313K ﹤0.01%
22,480
+18,079
+411% +$189K

Similar funds

Morgan Stanley's Q2 2026 Portfolio in Review

As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
  • Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
  • Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
  • Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
  • Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.